NASDAQ:AKBA
Akebia Therapeutics Stock News
$1.83
-0.410 (-18.30%)
At Close: Mar 28, 2024
Are Medical Stocks Lagging Akebia Therapeutics (AKBA) This Year?
10:53am, Friday, 02'nd Jun 2023
Here is how Akebia Therapeutics (AKBA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Akebia Therapeutics to Present at Jefferies Healthcare Conference
08:30am, Friday, 02'nd Jun 2023
CAMBRIDGE, Mass. , June 2, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today
4 Hot Penny Stocks To Watch This Week
11:20am, Thursday, 01'st Jun 2023
In the world of investment, penny stocks hold a unique position. Often priced at $5 per share or less, these are typically shares of small-cap companies that trade at relatively low prices.
Akebia Therapeutics: Buy This Undervalued Stock At Just 77% Of Revenue
08:11am, Monday, 29'th May 2023
Akebia Therapeutics Inc. is rated a Strong Buy due to its overly discounted revenue and strong prospects in the large Chronic Kidney Disease market. The company's valuation should be at least $716 mil
Why Shares of Akebia Therapeutics Were Up Tuesday
11:27am, Tuesday, 23'rd May 2023
Akebia gained approval for Vafseo, its anemia therapy for chronic kidney disease patients, in Great Britain. The company is awaiting word on its appeal to the FDA to get approval for the therapy in th
Akebia Therapeutics, Inc. (AKBA) Q1 2023 Earnings Call Transcript
10:25am, Monday, 08'th May 2023
Akebia Therapeutics, Inc. (NASDAQ:AKBA ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mercedes Carrasco - Senior Director of Investor and Corporate Communications John
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
09:54am, Monday, 08'th May 2023
Akebia Therapeutics (AKBA) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago.
4 Top Penny Stocks To Buy According To Analysts, Targets Up To 695%
11:12am, Thursday, 27'th Apr 2023
Analysts say these could be penny stocks to buy. Do you agree with their outlook?
Penny Stocks To Buy? 4 To Watch Now After Big News This Week
12:52pm, Monday, 03'rd Apr 2023
Penny stocks to watch with news this week. Are they a buy now or should you avoid them entirely?
10 Hot Penny Stocks Under $1 To Watch This Week
02:31pm, Thursday, 09'th Mar 2023
Penny stocks under $1 to watch right now. The post 10 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Akebia Therapeutics (AKBA) Reports Q4 Loss, Tops Revenue Estimates
09:53am, Thursday, 09'th Mar 2023
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 71.43% and 14.14%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
7 Hot Penny Stocks Under $1 To Watch This Week
02:23pm, Tuesday, 07'th Mar 2023
Penny stocks under $1 to watch this week. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Penny Stocks Insiders Are Active In, Time To Buy Or Sell Now?
11:03am, Friday, 03'rd Mar 2023
Penny stocks insiders are selling? What the details suggest.
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
06:40pm, Friday, 24'th Feb 2023 Benzinga
Gainers
Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.
Cingulate Inc (NASDAQ: CING) rose 6
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
12:56pm, Friday, 24'th Feb 2023 Benzinga
Gainers
Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD.
Akebia Therapeutics In